data
Novo Holdings Invests in Oxford Nanopore TechnologiesÂ
August 1, 2024Research and Development Microbiology, Novo Holdings, Oxford Nanopore Technologies, biopharmacuticals, biotech, data, drug therapies, investment
leading life science investor Novo Holdings, announced a £50m investment in Oxford Nanopore Technologies. Oxford Nanopore Technologies is a leading …
Inizio Engage and Nye Health form a strategic alliance to enhance patient support and outcomesÂ
August 1, 2024Research and Development Contraception, Inizio Engage, NHS, Nye Health, alliance, data, patient data, patient experience, support
 Nye Health’s digital platform will be coupled with the patient support experience available at Inizio Engage. The integrated approach will …
GSK shares data from global shingles survey
December 1, 2023Medical Communications GSK, Infections and infestations, data, shingles
GSK has announced data from its new global survey about shingles. The data suggests that there are some significant gaps …
COVID chaos: Survey reveals global oncology trial disruptions
June 10, 2021data, oncology
The pandemic has had a widespread impact across the healthcare industry and the world, however, a recent global survey from …
COVID Symptom Study app reveals most common vaccine side effects
April 28, 2021Research and Development COVID-19, Vaccine, data
An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …
BC Platforms partners with Australian Tissue Bank to improve breast cancer treatment
April 13, 2021Manufacturing and Production Cancer, data
BC Platforms have announced a data partnership with the Australian Breast Cancer Tissue Bank (ABCTB) for its BCRQUEST.com Global Data …
COVID-19 vaccine data leaked online by hackers, EMA says
January 14, 2021EMA, Pfizer, Vaccine, data
The EMA has confirmed that data relating to COVID-19 medicines and vaccines that was stolen by hackers in December have …
Researchers use machine learning to re-identify ‘anonymous data’
July 24, 2019Research and Development Big Data, anonymous data, data, patient data, privacy, research
Anonymised data can be traced back to individuals, according to research published in the journal Nature Communications. Anonymised data can …
The missing link: Blockchain in clinical data management
June 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, blockchain, data, data management, pharma, supply chain
Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges …
GDPR and Human Data Samples: Being ‘somewhat prepared’ is not enough
September 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, biotech, data, drugs, pharma, pharmaceutical
Thomas Hirse, Partner, and Paetrick Sakowski, Associate, CMS, discuss what pharmaceutical companies need to be aware of ahead of the …
Data-driven insights: Keeping pace with the technological boom
June 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, data, technology
If you want to understand the importance of data, look at Google and Facebook – neither company is out of …
Huge data loss puts NHS privatisation and Health Secretary under pressure
February 28, 2017Manufacturing and Production Jeremy Hunt, NHS, data
It has been revealed that a private company, responsible for delivering NHS data, accidentally stored 708,000 pieces of patient data …
New Humira data shows improved quality of life in ulcerative colitis patients
June 23, 2016Research and Development AbbVie, Humira, data, ulcerative colitis
New data on Humira (adalimumab) has been presented at the British Society of Gastroenterology, demonstrating the drug’s efficacy and improvement …
FDA expands Imbruvica label with new survival data
May 11, 2016Research and Development, Sales and Marketing AbbVie, FDA, Janssen, data, efficacy, expanded, imbruvica, label, late stage, phase III
The US Food and Drug Administration (FDA) has expanded the label of Imbruvica (ibrutinib) to include the data from recent …
